Acadia Healthcare Company Inc.

61.35-0.1700-0.28%Vol 15.53K1Y Perf 180.90%
Apr 23rd, 2021 10:00 DELAYED
BID61.34 ASK61.55
Open61.88 Previous Close61.52
Pre-Market- After-Market-
 - -%  - -
Target Price
57.86 
Analyst Rating
Moderate Buy 2.30
Potential %
-5.96 
Finscreener Ranking
+     37.87
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
+     37.95
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
+     27.49
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Market Cap5.49B 
Earnings Rating
Neutral
Price Range Ratio 52W %
96.05 
Earnings Date
29th Apr 2021

Today's Price Range

60.6561.88

52W Range

21.2763.00

5 Year PE Ratio Range

-12.50603.80

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
-0.97%
1 Month
11.81%
3 Months
18.28%
6 Months
97.24%
1 Year
180.90%
3 Years
62.92%
5 Years
-2.86%
10 Years
-

TickerPriceChg.Chg.%
ACHC61.35-0.1700-0.28
AAPL133.091.15000.87
GOOG2 284.2716.35000.72
MSFT258.271.10000.43
XOM55.570.30000.54
WFC43.420.72001.69
JNJ164.82-0.3600-0.22
FB298.011.49000.50
GE13.530.12000.89
JPM148.371.00000.68
Financial StrengthValueIndustryS&P 500US Markets
0.50
1.90
0.62
1.71
2.20
Leverage Ratio 3.00
ProfitabilityValueIndustryS&P 500US Markets
95.80
16.40
20.90
4.40
-57.83
RevenueValueIndustryS&P 500US Markets
1.31B
14.62
-9.07
1.35
Earnings HistoryEstimateReportedSurprise %
Q04 20200.691.1363.77
Q03 20200.550.6823.64
Q02 20200.380.5442.11
Q01 20200.370.4213.51
Q04 20190.490.514.08
Q03 20190.530.52-1.89
Q02 20190.590.613.39
Q01 20190.350.3911.43
Earnings Per EndEstimateRevision %Trend
3/2021 QR0.45-13.46Negative
6/2021 QR0.59-10.61Negative
12/2021 FY2.35-11.32Negative
12/2022 FY2.74-4.53Negative
Next Report Date29th Apr 2021
Estimated EPS Next Report0.45
Estimates Count4
EPS Growth Next 5 Years %12.80
Volume Overview
Volume15.53K
Shares Outstanding89.41M
Trades Count151
Dollar Volume39.42M
Avg. Volume577.68K
Avg. Weekly Volume411.28K
Avg. Monthly Volume445.06K
Avg. Quarterly Volume594.09K

Acadia Healthcare Company Inc. (NASDAQ: ACHC) stock closed at 61.52 per share at the end of the most recent trading day (a -1.65% change compared to the prior day closing price) with a volume of 476.75K shares and market capitalization of 5.49B. Is a component of Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 42800 people. Acadia Healthcare Company Inc. CEO is Debra K. Osteen.

The one-year performance of Acadia Healthcare Company Inc. stock is 180.9%, while year-to-date (YTD) performance is 22.4%. ACHC stock has a five-year performance of -2.86%. Its 52-week range is between 21.27 and 63, which gives ACHC stock a 52-week price range ratio of 96.05%

Acadia Healthcare Company Inc. currently has a PE ratio of -8.10, a price-to-book (PB) ratio of 2.92, a price-to-sale (PS) ratio of 4.16, a price to cashflow ratio of 8.40, a PEG ratio of 2.32, a ROA of -9.61%, a ROC of 3.80% and a ROE of -29.05%. The company’s profit margin is -57.83%, its EBITDA margin is 20.90%, and its revenue ttm is $1.31 Billion , which makes it $14.62 revenue per share.

Of the last four earnings reports from Acadia Healthcare Company Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.45 for the next earnings report. Acadia Healthcare Company Inc.’s next earnings report date is 29th Apr 2021.

The consensus rating of Wall Street analysts for Acadia Healthcare Company Inc. is Moderate Buy (2.3), with a target price of $57.86, which is -5.96% compared to the current price. The earnings rating for Acadia Healthcare Company Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Acadia Healthcare Company Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Acadia Healthcare Company Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 10.80, ATR14 : 2.21, CCI20 : 139.61, Chaikin Money Flow : 0.08, MACD : 2.37, Money Flow Index : 67.70, ROC : 4.98, RSI : 62.25, STOCH (14,3) : 76.40, STOCH RSI : 0.25, UO : 60.00, Williams %R : -23.60), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Acadia Healthcare Company Inc. in the last 12-months were: Christopher L. Howard (Option Excercise at a value of $382 402), Christopher L. Howard (Sold 33 228 shares of value $1 930 214 ), David Duckworth (Option Excercise at a value of $426 432), David Duckworth (Sold 18 780 shares of value $1 089 991 ), Reeve B. Waud (Sold 354 065 shares of value $12 799 201 ), William F. Grieco (Option Excercise at a value of $33 000), William F. Grieco (Sold 4 000 shares of value $239 340 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (30.00 %)
3 (30.00 %)
3 (30.00 %)
Moderate Buy
1 (10.00 %)
1 (10.00 %)
1 (10.00 %)
Hold
6 (60.00 %)
6 (60.00 %)
6 (60.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
2.30
Moderate Buy
2.30
Moderate Buy
2.30

Acadia Healthcare Company Inc.

Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities in the United States, United Kingdom, and Puerto Rico. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The U.S. facilities receive the largest proportion of payments from Medicaid, with the second largest proportion from commercial payors. In the United Kingdom, the majority of Acadia's revenue comes from its healthcare facilities, and virtually all of the payment received is from the National Health Service.

CEO: Debra K. Osteen

Telephone: +1 615 861-6000

Address: 6100 Tower Circle, Franklin 37067, TN, US

Number of employees: 42 800

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

59%41%

Bearish Bullish

58%42%

Bearish Bullish

63%38%

News

Stocktwits